Dr. Sean D. Delshad, MD

Dr. Delshad practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Delshad's NPI, 1265894257, was assigned on March 28, 2016. Dr. Delshad graduated from Boston University School Of Medicine in 2015. Dr. Delshad's California license number on file is A153480.

Dr. Delshad's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Delshad's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Delshad is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Delshad to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delshad practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Delshad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Delshad is board certified in internal medicine by the American Board of Internal Medicine. Dr. Delshad has a license on file in California.

Dmand AI lists cardiac arrhythmia, chronic respiratory failure, congestive heart failure, dementia, gastrointestinal bleeding, gastrointestinal inflammation, pulmonary embolism and sepsis among the conditions Dr. Delshad treats.

CMS data shows 439 Medicare services from Dr. Delshad across 5 procedure codes in 2024, for 173 Medicare patients. Medicare paid $40,457 for them.

CMS counts 173 Medicare patients who saw Dr. Delshad in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have arthritis, and 75% have high blood pressure. 41% are also on Medicaid. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delshad's median patient age at 61, with 47% women.

In 2024, Dr. Delshad wrote 67 Medicare Part D claims for 34 patients. 91% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $2,415 in total drug cost. In 2021, CMS named 72 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Delshad for performance year 2024, reported as part of a group. Dr. Delshad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Delshad, published from 2010 to 2023. The most frequent topics are Magnetic Resonance Imaging. Dr. Delshad's most frequent co-authors are Christopher Velasquez Almario, MD, William D. Chey, MD and Rajesh Kumar, MD.

CMS Open Payments shows 2 general payments to Dr. Delshad from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Esperion Therapeutics, Inc. paid the most, $130.

Dmand AI lists 5 awards for Dr. Delshad, most recently Commendation for Excellence in Medical Student Teaching in 2019. Dr. Delshad serves on Clinical Excellence Committee UCLA Medical Center.

Dr. Delshad graduated from Boston University School Of Medicine in 2015. Dr. Delshad is a member of ACP, AMA and MMS.

Dr. Delshad is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.